Skip to Content
Also part of the UPMC family:

Erin K. McCreary, Pharm.D.

  • Director of Infectious Diseases Improvement and Clinical Research Innovation at UPMC 
  • Infectious diseases pharmacist at UPMC
  • Clinical assistant professor at the University of Pittsburgh School of Medicine 

Dr. McCreary’s practice interests include infectious diseases and antimicrobial stewardship in immunocompromised patients, antimicrobial resistance and combination therapies, and antimicrobial pharmacokinetic/pharmacodynamic optimization.

In addition to serving as a member of the Division of Infectious Diseases at UPMC and the University of Pittsburgh and an infectious diseases clinical pharmacist, Dr. McCreary co-chairs the UPMC COVID-19 Therapeutics Committee and serves as a co-investigator for the REMAP-CAP trial, a global, adaptive, clinical trial evaluating multiple therapies for COVID-19. She is the pharmacist lead for the UPMC monoclonal antibody treatment network and Evusheld pre-exposure prophylaxis network.

She also serves on the Society of Infectious Diseases Pharmacists (SIDP) Executive Board and as a member of the ASM Microbe Planning Committee. 

Dr. McCreary received a Doctor of Pharmacy degree from the Auburn University Harrison School of Pharmacy. She completed residencies in both PGY1 Pharmacy Practice and PGY2 Infectious Diseases at the University of Wisconsin.